Brief: Orchid Pharma received the EIR from USFDA
Dec 31 (Reuters) - Orchid Pharma Ltd ORCD.NS : * Received the EIR from USFDA based on the successful inspection closure for the formulation manufacturing facility located at Irungattukottai * Source text for Eikon ID:nBSEMvzh9 ((For more news, please click here ORCD.NS )) ((Bengaluru Newsroom; +91 80 6749 1130))
Recent news on Orchid Pharma
See all newsBrief: Orchid Pharma Approves Enabling Resolution To Explore Fund Raising Via Equity Or Other Securities
Brief: Orchid Pharma To Consider And Evaluate Various Options For Raising Funds
Brief: Orchid Pharma June-Quarter Consol Profit 25.8 Million Rupees
India's Orchid Pharma jumps on pact to commercialize Exblifep in Russia
Refile: INDIA STOCKS-Indian shares set to open lower as US-Iran tensions lift oil prices